L Sideris
Overview
Explore the profile of L Sideris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bodie G, Hagen J, Almamar A, Majumdar S, Wang X, Tuepah R, et al.
Can J Surg
. 2022 Apr;
55(4 Suppl 1):S63-S135.
PMID: 35488395
No abstract available.
2.
Chiu J, Apriasz I, Alkhamesi N, Lal A, Lindsay D, Smith L, et al.
Can J Surg
. 2022 Apr;
54(4):S57-S104.
PMID: 35488394
No abstract available.
3.
Unger B, Gillman L, Hickey K, Pace D, Lam-Tin-Cheung K, Catton J, et al.
Can J Surg
. 2022 Apr;
64(6 Suppl 2):S80-S159.
PMID: 35483046
No abstract available.
4.
BrindAmour A, Dube P, Tremblay J, Soucisse M, Mack L, Bouchard-Fortier A, et al.
Curr Oncol
. 2020 Dec;
27(6):e621-e631.
PMID: 33380878
Modern management of colorectal cancer (crc) with peritoneal metastasis (pm) is based on a combination of cytoreductive surgery (crs), systemic chemotherapy, and hyperthermic intraperitoneal chemotherapy (hipec). Although the role of...
5.
Lo Dico R, Faron M, Yonemura Y, Glehen O, Pocard M, Sardi A, et al.
Eur J Surg Oncol
. 2020 Sep;
47(1):89-100.
PMID: 32943276
No abstract available.
6.
Tiberi D, Vavassis P, Nguyen D, Guilbert M, Simon-Cloutier A, Dube P, et al.
Curr Oncol
. 2020 Jul;
27(3):155-158.
PMID: 32669925
Introduction: Standard treatment for early-stage invasive breast cancer (bca) consists of breast-conserving surgery and several weeks of adjuvant radiotherapy (rt). Neoadjuvant single-fraction rt is a novel approach for early-stage bca....
7.
Badrudin D, Sideris L, Leblond F, Pichette V, Cloutier A, Drolet P, et al.
Surg Oncol
. 2018 Jun;
27(2):275-279.
PMID: 29937182
Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin (OX) is the standard of care for selected patients with peritoneal carcinomatosis of colorectal origin. Because 5-FU is mandatory to...
8.
Bosse D, Ng T, Ahmad C, AlFakeeh A, Alruzug I, Biagi J, et al.
Curr Oncol
. 2017 Jan;
23(6):e605-e614.
PMID: 28050151
The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016 was held in Montreal, Quebec, 5-7 February. Experts in radiation oncology, medical oncology, surgical oncology, and infectious diseases involved in the...
9.
Dube P, Sideris L, Law C, Mack L, Haase E, Giacomantonio C, et al.
Curr Oncol
. 2015 Apr;
22(2):e100-12.
PMID: 25908915
To meet the needs of patients, Canadian surgical and medical oncology leaders in the treatment of peritoneal surface malignancies (psms), together with patient representatives, formed the Canadian HIPEC Collaborative Group...
10.
Doyon C, Sideris L, Leblanc G, Leclerc Y, Boudreau D, Dube P
Int J Surg Oncol
. 2013 Jan;
2012:761576.
PMID: 23316352
Purpose. Proven efficacy of imatinib mesylate in gastrointestinal stromal tumour (GIST) has led to its use in advanced disease and, more recently, in adjuvant and neoadjuvant settings. The purpose of...